Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 11, 2022 08:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma Announces Research Collaboration with Dualsystems Biotech AG to Identify 10 New Therapeutic Targets

SAN DIEGO, Oct. 11, 2022 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE) (aTyr or “the Company”), a biotherapeutics company engaged in the discovery and development of first-in-class medicines...
October 04, 2022 08:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma to Participate in RBC Biotech Expert Insights: Pulmonary/Lung Disease Mini-Symposium

SAN DIEGO, Oct. 04, 2022 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary...
September 29, 2022 08:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma Announces Notice of Allowance for U.S. Patent for Anti-Neuropilin-2 (NRP2) Monoclonal Antibodies

SAN DIEGO, Sept. 29, 2022 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary...
September 27, 2022 08:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma Announces Dosing of First Patient in Pivotal Phase 3 EFZO-FIT™ Study of Efzofitimod in Patients with Pulmonary Sarcoidosis

Multiple centers in the U.S. are open for enrollment for double-blind, randomized, placebo-controlled study. Primary endpoint will evaluate steroid-sparing effect of efzofitimod compared to placebo. ...
September 16, 2022 10:00 ET | Source: Will Winn Games

Experience a Pirate’s Life in Multiplayer Arcade Brawler Plunder Panic, Out Now With Crossplay Between All Major Consoles and Windows PC/Mac

EAST LANSING, Mich., Sept. 16, 2022 (GLOBE NEWSWIRE) -- Ahoy, Me Hearties! Hoist the Jolly Roger and sharpen those cutlasses, as Will Winn Games’ pirate-themed online multiplayer brawler Plunder...
September 13, 2022 08:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma Receives FDA Fast Track Designation for Efzofitimod for Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD)

Second Fast Track designation for efzofitimod clinical program. Efzofitimod previously received FDA orphan drug designation for systemic sclerosis (SSc). SAN DIEGO, Sept. 13, 2022 (GLOBE NEWSWIRE)...
September 12, 2022 04:03 ET | Source: Research and Markets

Global Home Improvement Market to Grow by 5.23% Annually Through 2026

Dublin, Sept. 12, 2022 (GLOBE NEWSWIRE) -- The "Global Home Improvement Market, By Product (Building and Remodeling, Home Decor, Tools and Hardware and Outdoor Living), By Project (DIFM and DIY), By...
September 06, 2022 08:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma to Present at the H.C. Wainwright 24th Annual Global Investment Conference 2022

SAN DIEGO , Sept. 06, 2022 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary...
September 01, 2022 08:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma to Present Poster at the European Respiratory Society (ERS) International Congress 2022

SAN DIEGO, Sept. 01, 2022 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary...
August 17, 2022 12:30 ET | Source: Straits Research

Property Management Market Size is projected to reach USD 39.51 Billion by 2030, growing at a CAGR of 10.21%: Straits Research

New York, United States, Aug. 17, 2022 (GLOBE NEWSWIRE) -- The property management software offers a centralized location to view all properties and allows for managing other property-related...